Logo image of CDTG

CDT ENVIRONMENTAL TECHNOLOGY (CDTG) Stock Fundamental Analysis

NASDAQ:CDTG - Nasdaq - KYG2030P1072 - Common Stock - Currency: USD

1.39  -0.08 (-5.44%)

Fundamental Rating

4

Overall CDTG gets a fundamental rating of 4 out of 10. We evaluated CDTG against 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and the financial health of CDTG get a neutral evaluation. Nothing too spectacular is happening here. CDTG has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CDTG had positive earnings in the past year.
In the past year CDTG has reported a negative cash flow from operations.
CDTG Yearly Net Income VS EBIT VS OCF VS FCFCDTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

With an excellent Return On Assets value of 12.98%, CDTG belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
CDTG's Return On Equity of 29.63% is amongst the best of the industry. CDTG outperforms 92.86% of its industry peers.
CDTG's Return On Invested Capital of 22.26% is amongst the best of the industry. CDTG outperforms 95.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CDTG is significantly above the industry average of 10.88%.
The 3 year average ROIC (20.03%) for CDTG is below the current ROIC(22.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.98%
ROE 29.63%
ROIC 22.26%
ROA(3y)12.45%
ROA(5y)N/A
ROE(3y)26.08%
ROE(5y)N/A
ROIC(3y)20.03%
ROIC(5y)N/A
CDTG Yearly ROA, ROE, ROICCDTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 10 20 30

1.3 Margins

With an excellent Profit Margin value of 19.03%, CDTG belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
With an excellent Operating Margin value of 22.06%, CDTG belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
CDTG has a Gross Margin of 32.63%. This is comparable to the rest of the industry: CDTG outperforms 51.19% of its industry peers.
Industry RankSector Rank
OM 22.06%
PM (TTM) 19.03%
GM 32.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CDTG Yearly Profit, Operating, Gross MarginsCDTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CDTG is creating value.
Compared to 1 year ago, CDTG has about the same amount of shares outstanding.
Compared to 1 year ago, CDTG has a worse debt to assets ratio.
CDTG Yearly Shares OutstandingCDTG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
CDTG Yearly Total Debt VS Total AssetsCDTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M

2.2 Solvency

CDTG has an Altman-Z score of 2.31. This is not the best score and indicates that CDTG is in the grey zone with still only limited risk for bankruptcy at the moment.
CDTG has a Altman-Z score (2.31) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.27 indicates that CDTG is not too dependend on debt financing.
The Debt to Equity ratio of CDTG (0.27) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 2.31
ROIC/WACC3.8
WACC5.85%
CDTG Yearly LT Debt VS Equity VS FCFCDTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

CDTG has a Current Ratio of 1.60. This is a normal value and indicates that CDTG is financially healthy and should not expect problems in meeting its short term obligations.
CDTG's Current ratio of 1.60 is fine compared to the rest of the industry. CDTG outperforms 64.29% of its industry peers.
CDTG has a Quick Ratio of 1.60. This is a normal value and indicates that CDTG is financially healthy and should not expect problems in meeting its short term obligations.
CDTG's Quick ratio of 1.60 is fine compared to the rest of the industry. CDTG outperforms 72.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
CDTG Yearly Current Assets VS Current LiabilitesCDTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M

1

3. Growth

3.1 Past

CDTG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.39%, which is quite good.
The Revenue has been growing slightly by 5.83% in the past year.
EPS 1Y (TTM)15.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.25%
Revenue 1Y (TTM)5.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CDTG Yearly Revenue VS EstimatesCDTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 10M 20M 30M
CDTG Yearly EPS VS EstimatesCDTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

4

4. Valuation

4.1 Price/Earnings Ratio

CDTG is valuated cheaply with a Price/Earnings ratio of 1.65.
98.81% of the companies in the same industry are more expensive than CDTG, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.35. CDTG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 1.65
Fwd PE N/A
CDTG Price Earnings VS Forward Price EarningsCDTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CDTG indicates a rather cheap valuation: CDTG is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.3
CDTG Per share dataCDTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The decent profitability rating of CDTG may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CDTG!.
Industry RankSector Rank
Dividend Yield N/A

CDT ENVIRONMENTAL TECHNOLOGY

NASDAQ:CDTG (3/7/2025, 8:11:27 PM)

1.39

-0.08 (-5.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.38%
Inst Owner Change15485.4%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.87M
AnalystsN/A
Price TargetN/A
Short Float %0.85%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.65
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB 0.47
EV/EBITDA 1.3
EPS(TTM)0.84
EY60.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS4.64
BVpS2.98
TBVpS2.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.98%
ROE 29.63%
ROCE 33.96%
ROIC 22.26%
ROICexc 22.4%
ROICexgc 22.41%
OM 22.06%
PM (TTM) 19.03%
GM 32.63%
FCFM N/A
ROA(3y)12.45%
ROA(5y)N/A
ROE(3y)26.08%
ROE(5y)N/A
ROIC(3y)20.03%
ROIC(5y)N/A
ROICexc(3y)20.51%
ROICexc(5y)N/A
ROICexgc(3y)20.52%
ROICexgc(5y)N/A
ROCE(3y)28.4%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA 0.75
Cap/Depr 6.3%
Cap/Sales 0.04%
Interest Coverage 103.28
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 2.31
F-Score4
WACC5.85%
ROIC/WACC3.8
Cap/Depr(3y)20.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.96%
OCF growth 3YN/A
OCF growth 5YN/A